Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

XCath Robotics receives FDA breakthrough nod for Iris system

15 September 2026 · By · Wire by Fusion42

Published

15 September 2026

Topic

opportunities

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at massdevice.com →

◆ Verified

Fusion42 · 15 September 2026 · Fusion42 review

XCath Robotics has received FDA Breakthrough Device Designation for its Iris surgical robotic system, enabling greater regulatory engagement to advance remote mechanical thrombectomy treatment for acute ischemic stroke.

This Wire brief sits within Fusion42's coverage of Medtech, and 2 sources have reported it between 10 Sep 2026 and 15 Sep 2026.

◆ ◆ The Wire takeaway

Your Medtech startup can now see faster FDA support paths for stroke robotic devices as XCath Robotics sets a precedent for remote thrombectomy technology.

◆ Coverage

2 sources · first reported 10 Sep 2026 · latest 15 Sep 2026

◆ Related on Wire

◆ Topics

Medtechfda-breakthroughstroke-caresurgical-roboticsremote-treatmentmedtech